论文部分内容阅读
目的:探讨介入治疗子宫瘢痕部位妊娠的临床疗效。方法:选取2009年1月～2011年12月进行介入治疗的72例子宫瘢痕部位妊娠患者为观察组,同期以甲氨蝶呤肌内注射治疗的72例患者为对照组,将两组患者的治愈率、住院时间、并发症发生率、治疗前及治疗后3天、7天的血清PAPP-A、VEGF、INH-A、β-HCG、病灶部位血供相关指标进行比较。结果:观察组的治愈率高于对照组(P<0.05),住院时间短于对照组(P<0.05),并发症发生率低于对照组(P<0.05),治疗后3天及7天的血清PAPP-A、VEGF、INH-A、β-HCG、病灶部位血供相关指标改善幅度均大于对照组(P<0.05)。结论:介入治疗子宫瘢痕部位妊娠的临床疗效较好,可从多方面改善患者的疾病状态。
Objective: To investigate the clinical effect of interventional treatment of uterine scar site pregnancy. Methods: Seventy-two patients with uterine scar pregnancy were selected as the observation group during the interventional treatment from January 2009 to December 2011. In the same period, 72 patients treated with intramuscular injection of methotrexate were used as the control group. The patients in the two groups Cure rate, length of hospital stay, complication rate, serum PAPP-A, VEGF, INH-A, β-HCG and blood supply of lesion site before and 3 days and 7 days after treatment were compared. Results: The cure rate of the observation group was higher than that of the control group (P0.05), the length of stay was shorter than that of the control group (P0.05), the complication rate was lower than that of the control group (P0.05), the days 3 and 7 The serum levels of PAPP-A, VEGF, INH-A, β-HCG and lesion site were significantly higher than those of the control group (P <0.05). Conclusion: Interventional treatment of uterine scar site pregnancy clinical efficacy is good, can improve the patient’s condition in many ways.